Ultragenyx (RARE) grants EVP 28,895 RSUs and 49,960 options
Rhea-AI Filing Summary
Ultragenyx Pharmaceutical Inc. reported that EVP and Chief Legal Officer Karah Herdman Parschauer received an equity compensation package consisting of restricted stock units and stock options. She was granted 28,895 RSUs under the company’s 2023 Incentive Plan, vesting 25% on each anniversary of the grant date over four years. She was also granted a stock option for 49,960 shares of common stock at an exercise price of $24.52 per share, expiring on April 16, 2036, with 25% vesting after one year and the remainder vesting monthly thereafter. Following these grants, she directly holds 95,715 shares of common stock, including shares underlying previously reported RSUs that remain subject to vesting conditions.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 28,895 shares
Net Buy
2 txns
Insider
Parschauer Karah Herdman
Role
EVP and Chief Legal Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 49,960 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 28,895 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 49,960 shares (Direct);
Common Stock — 95,715 shares (Direct)
Footnotes (3)
- F1. Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date
- F2. Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
- F3. On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.
Key Figures
RSU grant: 28,895 RSUs
Stock option grant: 49,960 options
Option exercise price: $24.52 per share
+4 more
7 metrics
RSU grant
28,895 RSUs
Granted under 2023 Incentive Plan with 4-year annual vesting
Stock option grant
49,960 options
Right to buy common stock, granted April 16, 2026
Option exercise price
$24.52 per share
Conversion or exercise price for 49,960-share option
Option expiration
April 16, 2036
Expiration date of stock option grant
Shares held after awards
95,715 shares
Total common stock directly held after RSU and option grants
RSU vesting schedule
25% per year
RSUs vest 1/4 on each anniversary over four years
Option initial vesting
25% after one year
1/4 of option shares vest on first anniversary of grant
Key Terms
Restricted Stock Units ("RSUs"), 2023 Incentive Plan, Stock Option (Right to Buy), vesting conditions, +1 more
5 terms
Restricted Stock Units ("RSUs") financial
"Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
2023 Incentive Plan financial
"Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan."
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) with underlying security title Common Stock."
vesting conditions financial
"which are subject to certain vesting conditions."
Vesting conditions are the rules that determine when someone earning company stock or stock options actually gains the right to keep or sell them, typically based on staying with the company for a set time or meeting performance targets. Think of it like keys that unlock gradually — some unlock by calendar date, others only after agreed milestones. Investors care because vesting shapes management incentives, the timing of share sales, and the number of shares that can enter the market, which can affect a company's valuation and ownership mix.
Option Anniversary Date financial
"On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest;"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What equity awards did Ultragenyx (RARE) grant to Karah Herdman Parschauer?
Ultragenyx granted Karah Herdman Parschauer 28,895 restricted stock units and a stock option for 49,960 shares. These awards are part of her compensation and provide future share ownership subject to time-based vesting schedules and an exercise price of $24.52 for the option.
How do the new RSUs for Ultragenyx (RARE) EVP vest over time?
The 28,895 RSUs vest in four equal annual installments, with 25% of the underlying shares vesting on each anniversary of the grant date. This structure encourages long-term retention by tying actual share delivery to continued service over a four-year period.
What are the key terms of the new stock option granted by Ultragenyx (RARE)?
The new option covers 49,960 shares of common stock at a $24.52 exercise price and expires on April 16, 2036. One-quarter of the shares vest on the first anniversary of the grant, with the remaining shares vesting in equal monthly installments thereafter.
Are the Ultragenyx (RARE) awards to Karah Herdman Parschauer open-market purchases?
No. The Form 4 shows the awards as grants under the company’s 2023 Incentive Plan, with a transaction code indicating grant or award. The RSUs and stock options were issued at no cash cost per share on the grant date, not bought in the open market.